首頁 › 頭頸部鱗狀細胞癌 › 華盛頓州 › Seattle
Seattle, WA 的 頭頸部鱗狀細胞癌 臨床試驗
11 項針對 頭頸部鱗狀細胞癌 的研究正在 Seattle(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
招募中2/3 期
- Site # 0159, Seattle
- Site #0125, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- University of Washington Fred Hutchinson, Seattle
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 還有 1 項
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
招募中1/2 期
- Fred Hutchinson Cancer Center, Seattle
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
招募中觀察性研究
- University of Washington, Seattle
SMP-3124LP in Adults With Advanced Solid Tumors
招募中1/2 期
- University of Washington, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 頭頸部鱗狀細胞癌 試驗
- Houston, TX47 項研究
- Los Angeles, CA42 項研究
- Boston, MA40 項研究
- New York City, NY39 項研究
- Nashville, TN39 項研究
- St. Louis, MO28 項研究
- Arlington, VA26 項研究
- Philadelphia, PA26 項研究
- Chicago, IL26 項研究
- Atlanta, GA24 項研究
- San Antonio, TX22 項研究
- New Haven, CT22 項研究
Seattle 的其他研究
- 非小細胞肺癌53 項研究
- 癌症(所有類型)49 項研究
- 前列腺癌42 項研究
- 急性髓系白血病41 項研究
- 乳癌39 項研究
- 轉移性癌症39 項研究
- 大腸直腸癌34 項研究
- 肺癌33 項研究
- 卵巢癌30 項研究
- 多發性骨髓瘤22 項研究
- 膀胱癌21 項研究
- 骨髓增生異常症候群21 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。